ESTUTC-5 New YorkLog in Sign up

MYGN
Myriad Genetics Inc
stockNASDAQ

At CloseNov 13, 2026 3:59:58 PM EST

5.64USD-0.704%(-0.04)1,051,779

Pre-marketNov 13, 2026 8:25:30 AM EST

5.75USD+1.232%(+0.07)

After-hoursNov 13, 2026 4:00:30 PM EST

5.66USD+0.355%(+0.02)

MYGN News

Day breaks

09:02 AM ESTMYGN Maintained by Stephens & Co. -- Price Target Raised to $6.00 ·

GuruFocus

06:52 AM ESTStephens raises Myriad Genetics stock price target on revenue beat ·

Investing.com

10:00 PM ESTMyriad Genetics, Inc. at UBS Global Healthcare Conference Transcript ·

GuruFocus

04:48 PM ESTMyriad Genetics at UBS Global Healthcare Conference: oncology pivot deepens ·

Investing.com

04:41 PM ESTMyriad Genetics, Inc. (MYGN) Presents at 2026 UBS Global Healthcare Conference Transcript ·

Seeking Alpha

04:03 PM ESTMYGN Maintained by TD Cowen -- Price Target Raised to $6.75 ·

GuruFocus

03:34 PM ESTMYGN Maintained by Leerink Partners -- Price Target Raised to $8.00 ·

GuruFocus

01:30 PM ESTMyriad Genetics (MYGN) Q3 2026 Earnings Call Transcript ·

The Motley Fool

11:05 AM ESTMyriad outlines $780M-$790M 2026 revenue outlook following $210M Prenatal Health divestiture deal ·

Seeking Alpha

11:04 AM ESTMyriad Genetics, Inc. (MYGN) Q3 2026 Earnings Call Transcript ·

Seeking Alpha

11:04 AM ESTMyriad unauthorized IT access prompted temporary testing, order suspension ·

Seeking Alpha

09:16 AM ESTMyriad Genetics reports unauthorized access to IT network, resumes most operations ·

Investing.com

04:13 AM ESTMyriad Genetics Inc (MYGN) Q3 2026 Earnings Call Highlights: Revenue Guidance Raised as ... ·

GuruFocus

11:01 PM ESTQ3 2026 Myriad Genetics, Inc. Earnings Call Transcript ·

GuruFocus

07:26 PM ESTMyriad Genetics earnings beat by $0.09, revenue topped estimates ·

Investing.com

04:39 PM ESTMyriad Genetics Reports Q3 2026 Revenue of $202.7M, GAAP EPS of -$0.46 Misses Estimates ·

GuruFocus

04:23 PM ESTMyriad Genetics Non-GAAP EPS of -$0.11 beats by $0.09, revenue of $202.7M beats by $11.37M ·

Seeking Alpha

10:00 AM ESTHere are the major earnings after the close Wednesday ·

Seeking Alpha

04:05 PM ESTMyriad Genetics to Participate in Upcoming Investor Healthcare Conferences ·

GlobeNewswire Inc.

09:05 AM EDTMyriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers ·

GlobeNewswire Inc.